Rigel Pharmaceuticals (RIGL) Inventory Average (2018 - 2026)

Rigel Pharmaceuticals' Inventory Average history runs 9 years deep, the most recent figure standing at $11.6 million for Q1 2026.

• On a quarterly basis, Inventory Average rose 117.22% year-over-year to $11.6 million in Q1 2026; TTM through Mar 2026 was $11.6 million, a 117.22% increase from a year earlier, with the FY2025 full-year figure at $8.8 million, up 51.93% from the prior year.
• Inventory Average retreated to $11.6 million in Q1 2026 per RIGL's latest filing, from $12.4 million in the prior quarter.
• Across five years, Inventory Average topped out at $12.4 million in Q4 2025 and bottomed at $5.3 million in Q1 2025.
• The 5-year median for Inventory Average is $7.3 million (2024), against an average of $8.1 million.
• Across the five-year window, Inventory Average tumbled 40.08% in 2024 and soared 130.01% in 2025, its largest moves.
• Year by year, Inventory Average stood at $8.1 million in 2022, then retreated by 28.34% to $5.8 million in 2023, then decreased by 7.29% to $5.4 million in 2024, then surged by 130.01% to $12.4 million in 2025, then dropped by 6.65% to $11.6 million in 2026.
• Per Business Quant, the three latest RIGL Inventory Average figures stand at $11.6 million (Q1 2026), $12.4 million (Q4 2025), and $11.9 million (Q3 2025).